f CPB," Dr. John G. Laffey, of the Clinical Sciences Institute at the National University of Ireland, wrote in an accompanying editorial.
The study results lend support to the feasibility of conducting human studies to examine the potential protective effects of CO on a number of organs.
"The demonstration that CO may reduce pulmonary inflammation and injury following CPB is an important and novel finding. Relative ease of administration, probable safety when given at low doses for short periods, and likely protective effects for multiple organs make this a fascinating agent with clear therapeutic promise," Laffey noted.
More information
The MedlinePlus Medical Encyclopedia has more about heart bypass surgery.
-- Robert Preidt
SOURCE: American Society of Anesthesiologists, news release, May 23, 2008
'/>"/>Copyright©2008 ScoutNews,LLC. All rights reserved | |
Page: 1 2 Related medicine news :1.
Carbon nanotubes that look like asbestos, behave like asbestos2.
Carbon Nanotubes That Look Like Asbestos, Behave Like Asbestos3.
ESA contributes to ocean carbon cycle research4.
MarketResearch.com Announces Distribution of CarbonFree Research5.
Reducing carbon emissions could help -- not harm -- US economy6.
Tracking your carbon footprint7.
Wiley-Blackwell renews carbon neutral commitment8.
Routine screenings uncover hidden carbon monoxide poisoning9.
UT Southwestern plastic surgeons deploy new carbon dioxide-based fractional laser10.
Hot liquids release potentially harmful chemicals in polycarbonate plastic bottles11.
Activists Raise Alarm for Seniors, Deliver Carbon Monoxide Detectors to Atria Marland Place